SUMMARY The efficiency of complement activation was studied in sera from HLA-B27 positive and negative subjects (27 with previous yersinia arthritis and 35 controls). Activation of complement with zymosan induced higher mean levels of the anaphylatoxin C3a in HLA-B27 positive sera (mean (SD) 7-40 (1-66) mg/i) than in HLA-B27 negative sera (6-41 (1-79) 
supported by the findings that polymorphonuclear leucocytes from HLA-B27 positive patients with reactive yersinia arthritis or ankylosing spondylitis, and from healthy subjects with HLA-B27, show increased chemotaxis in vitro5 and in vivo.6 It is also in agreement with the clinical observation that inflammatory symptoms are more severe in HLA-B27 positive patients with yersinia arthritis than in HLA-B27 negative patients.78 The reason for the aberrant polymorphonuclear leucocyte migration is unknown. The finding that after treatment with zymosan polymorphonuclear leucocyte migration in vitro is stimulated more by HLA-B27 positive sera than by HLA-B27 negative sera9 10 suggests that complement derived chemotaxins, such as C5a, may Accepted for publication 15 play a part. This prompted us to study whether activation of complement is, in itself, aberrant in sera from patients with previous yersinia arthritis and healthy subjects with HLA-B27.
Subjects and methods

SUBJECTS
Thirty HLA-B27 positive subjects (20 Increased efficiency of complement activation may thus be one of the factors affecting disease expression and severity of inflammation in patients with HLA-B27 associated diseases.
